| Literature DB >> 35896995 |
Frederick H F Chan1, Xiaowen Lin1, Konstadina Griva1, Mythily Subramaniam1,2, Ivan Ćelić3, Lorainne Tudor Car4,5.
Abstract
BACKGROUND: Previous studies have identified substantial unmet information needs in people with depression and anxiety. Sufficient information about the disorder, treatment, available services, and strategies for self-management is essential as it may influence quality of care and patients' quality of life. This scoping review aimed to provide a broad overview of information needs of people with depression and anxiety as well as the sources that they use to seek this information.Entities:
Keywords: Anxiety; Depression; Information need; Information seeking; Information source; Scoping review
Mesh:
Year: 2022 PMID: 35896995 PMCID: PMC9326147 DOI: 10.1186/s12888-022-04146-0
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 4.144
Fig. 1PRISMA flow diagram illustrating the search process
Summary of study characteristics
| Domain | Study Characteristics | No. (%) of Studies (N = 56) |
|---|---|---|
| Study Design | Cross-sectional (quantitative, qualitative, or mixed-method) | 51 (91.1%) |
| Experimental (RCT, sequential control, etc.) | 3 (5.4%) | |
| Cohort (prospective, longitudinal, etc.) | 2 (3.6%) | |
| Data Collection Methods | Quantitative | 31 (55.4%) |
| Qualitative | 20 (35.7%) | |
| Mixed-methods | 5 (8.9%) | |
| Location (by country) | United States | 13 (23.2%) |
| United Kingdom | 11 (19.6%) | |
| Germany | 9 (16.1%) | |
| Canada | 4 (7.1%) | |
| Australia | 3 (5.4%) | |
| South Africa | 2 (3.6%) | |
| Others | 14 (25.0%) | |
| Sample size | 0–50 | 19 (33.9%) |
| 51–100 | 17 (30.4%) | |
| 101–500 | 16 (28.6%) | |
| > 500 | 4 (7.1%) | |
| Mean age | 18–30 | 3 (5.4%) |
| 30–40 | 8 (14.3%) | |
| 40–50 | 11 (19.6%) | |
| > 50 | 6 (10.7%) | |
| Others (i.e., unreported) | 28 (50.0%) | |
| Mental health conditions | Depression only | 32 (57.1%) |
| Anxiety only | 4 (7.1%) | |
| Depression and anxiety | 20 (35.7%) | |
| Severity of conditions | Clinical diagnosis | 39 (69.6%) |
| Subclinical (self-reported symptoms) | 17 (30.4%) |
Information needs reported by studies on people with depression (k = 46 studies)
| Theme | Information needs | Number and percentage of studies |
|---|---|---|
| General facts about depression (k = 32; 69.6%) | Symptoms/signs of depression | 15 (46.9%) |
| General information on depression | 13 (40.6%) | |
| Diagnosis (diagnostic criteria; meaning of diagnosis) | 11 (34.4%) | |
| Aetiology (causes of depression; scientific details) | 10 (31.3%) | |
| Prognosis (length/course of depression; recovery) | 6 (18.8%) | |
| Information on suicidal thoughts | 4 (12.5%) | |
| Prevalence of depression | 3 (9.4%) | |
| Recent research on depression | 2 (6.3%) | |
| Whether depression is normal | 2 (6.3%) | |
| Environmental risk factors (e.g., stress, lifestyle) | 2 (6.3%) | |
| Risks of developing depression based on family history | 2 (6.3%) | |
| Behavioural problems (e.g., violence, drug/alcohol abuse) | 1 (3.1%) | |
| Treatment (k = 38; 82.6%) | Treatment options and comparison between options | 24 (63.2%) |
| Side effects of treatment | 19 (50.0%) | |
| Effectiveness/benefits of treatment and expected outcomes | 15 (39.5%) | |
| General information on medication | 14 (36.8%) | |
| Appropriate use of medication (e.g., dosage, long-term use, discontinuation) | 13 (34.2%) | |
| Length of treatment | 7 (18.4%) | |
| Explanation of specific procedures and approaches used | 4 (10.5%) | |
| Issues related to addiction, tolerance, and dependence of medication | 4 (10.5%) | |
| Adverse drug reactions | 4 (10.5%) | |
| Psychosocial or nonpharmacological interventions | 3 (7.9%) | |
| Mechanisms or (non-)pharmacological actions of medications | 2 (5.3%) | |
| Placebo/nocebo effects | 1 (2.6%) | |
| What does the prescribed dose indicate about patients’ condition | 1 (2.6%) | |
| Lived experience (k = 15; 32.6%) | Other people’s experience of depression in general | 10 (66.7%) |
| Other people’s experience of taking medications for depression | 4 (26.7%) | |
| Other people’s experience of recovery from depression | 2 (13.3%) | |
| Other people’s experience of antidepressant withdrawal and depression relapse | 1 (6.7%) | |
| Other people’s reasons to use antidepressants | 1 (6.7%) | |
| Previous patients’ experience of treatment | 1 (6.7%) | |
| Healthcare services (k = 24; 52.2%) | Available local services (e.g., hospitals, day treatment, rehabilitation) | 14 (58.3%) |
| How or where to get help | 8 (33.3%) | |
| Support groups & patient associations | 7 (29.2%) | |
| Healthcare professionals (e.g., psychologists, psychiatrists) | 6 (25.0%) | |
| Information on the mental health system | 2 (8.3%) | |
| Role of psychologists | 2 (8.3%) | |
| How to get a further supply of medication | 1 (4.2%) | |
| Coping & self-management (k = 17; 37.0%) | Strategies to cope with depression and alleviate symptoms | 13 (76.5%) |
| Improving independent living skills (coping with everyday life) | 5 (29.4%) | |
| Managing medication side effects | 4 (23.5%) | |
| Improving social relationships and communication skills | 3 (17.6%) | |
| Coping with stigma/discrimination | 3 (17.6%) | |
| Strategies to speed recovery or prevent exacerbation | 2 (11.8%) | |
| Coping with unpredictable variations in intensity and duration of depression | 1 (5.9%) | |
| Strategies for solving problems | 1 (5.9%) | |
| Dealing with weight gain | 1 (5.9%) | |
| What to do in case of no response to medication | 1 (5.9%) | |
| Financial & legal information (k = 8; 17.4%) | Financial assistance | 7 (87.5%) |
| Cost of treatment | 2 (25.0%) | |
| Mental health law | 1 (12.5%) | |
| Other information needs (k = 9; 19.6%) | Current health condition and other comorbid health problems | 2 (22.2%) |
| Social relationships and social isolation/avoidance/withdrawal | 2 (22.2%) | |
| How to figure out severity of mental disorder | 2 (22.2%) | |
| Interpretation of information from patient information leaflets and the internet | 1 (11.1%) | |
| What to do between visits | 1 (11.1%) | |
| Information for relatives | 1 (11.1%) | |
| Work-related challenges | 1 (11.1%) | |
| How to reduce the likelihood of depression for themselves and their family | 1 (11.1%) |
Information needs reported by studies on people with anxiety (k = 23 studies)
| Theme | Information Needs | Number and Percentage of Studies |
|---|---|---|
| General facts about anxiety (k = 17; 73.9%) | Symptoms | 9 (52.9%) |
| Diagnosis (diagnostic criteria; meaning of diagnosis) | 7 (41.2%) | |
| Aetiology (causes of anxiety; scientific details) | 5 (29.4%) | |
| General information on anxiety | 3 (17.6%) | |
| Prevalence of anxiety | 3 (17.6%) | |
| Prognosis (length/course of anxiety; recovery) | 3 (17.6%) | |
| Whether anxiety is normal | 2 (11.8%) | |
| Information on suicidal thoughts | 2 (11.8%) | |
| Risks of developing anxiety based on family history | 1 (5.9%) | |
| Treatment (k = 21; 91.3%) | Treatment options and comparison between options | 12 (57.1%) |
| Side effects of treatment | 11 (52.4%) | |
| General information on medication | 9 (42.9%) | |
| Effectiveness/benefits of treatment and expected outcomes | 7 (33.3%) | |
| Length of treatment | 4 (19.0%) | |
| Psychosocial or nonpharmacological interventions | 4 (19.0%) | |
| Appropriate use of medication (e.g., dosage) | 4 (19.0%) | |
| Mechanisms or (non-)pharmacological actions of medications | 3 (14.3%) | |
| Explanation of specific procedures and approaches used | 2 (9.5%) | |
| Issues related to addiction, tolerance, and dependence of medication | 2 (9.5%) | |
| Adverse drug reactions | 2 (9.5%) | |
| What does the prescribed dose indicate about patients’ condition | 1 (4.8%) | |
| Placebo/nocebo effects | 1 (4.8%) | |
| Lived experience (k = 7; 30.4%) | Other people’s experience of anxiety in general | 6 (85.7%) |
| Other people’s experience of taking medications for anxiety | 1 (14.3%) | |
| Other people’s experience of recovery from anxiety | 1 (14.3%) | |
| Healthcare services (k = 14; 60.9%) | Available local services (e.g., hospitals, clinics, day care) | 11 (78.6%) |
| Healthcare professionals (e.g., psychologists, psychiatrists) | 6 (42.9%) | |
| How or where to get help | 5 (35.7%) | |
| Support groups & patient associations | 5 (35.7%) | |
| Role of psychologists | 1 (7.1%) | |
| Coping & self-management (k = 8; 34.8%) | Strategies to cope with anxiety and alleviate symptoms | 7 (87.5%) |
| Improving independent living skills (coping with everyday life) | 3 (37.5%) | |
| Managing medication side effects | 1 (12.5%) | |
| What to do in case of no response to medication | 1 (12.5%) | |
| Strategies to improve self-esteem | 1 (12.5%) | |
| Coping with stigma/discrimination | 1 (12.5%) | |
| Financial & legal information (k = 3; 13.0%) | Financial assistance | 2 (66.7%) |
| Cost of treatment | 1 (33.3%) | |
| Mental health law | 1 (33.3%) | |
| Other information needs (k = 4; 17.4%) | Information for relatives | 2 (50.0%) |
| How to figure out severity of mental disorder | 1 (25.0%) | |
| Interpretation of information from patient information leaflets and the internet | 1 (25.0%) |
Fig. 2Publication frequency, by year, of included studies reporting each theme of information needs
Fig. 3Publication frequency, by year, of included studies reporting each category of information sources